New Alternative Surgical Technique for Managing Proximal Tibia Chronic Osteomyelitis: Anterior Approach with Establishment of Bone Marrow Communication via Intramedullary Reaming
Abstract
1. Introduction
2. Materials and Methods
2.1. Patients
2.2. Surgical Technique
2.3. Postoperative Antibiotics
2.4. Assessment of Treatment Outcomes
3. Results
3.1. The New Surgical Technique Enables Precise Targeting of the Infection Site Minimizing Unnecessary Bone Loss
3.2. The New Surgical Technique Largely Eliminates the Need for Internal Fixation with Metallic Implants After Curettage
3.3. Outcomes of the New Surgical Technique for the Treatment of Severe Post-Traumatic Chronic Osteomyelitis
3.4. Long-Term Follow-Up Results of the Anterior Approach and Osteoimmune Activation
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| C-M classification | Ciemy-Mader classification |
| G-A classification | Gustilo-Anderson classification |
| BM | bone marrow |
| SSI | surgical site infection |
| MTB | Mycobacterium tuberculosis |
| CoNS | coagulase-negative Stap/rylococcus |
| GBS | Streptococcus, beta-hemolytic, Group B |
| C. albicans | Candida albicans |
| S. marcescens | Serratia marcescens |
| MRSA | methicillin-resistant Staplylococcus aures |
| MSSA | methicillin-sensitive Staphylococcus aures |
| CP | cerebral palsy |
| SAH | subarachnoid hemorrhage |
| TIDM | type 1 diabetes mellitus |
| Uba | ubacillin |
| VCM | vancomycin |
| Tobra | tobramycin |
| Flu | flumarin |
| AMK | amikacin |
| AUG | Augmentin |
| INAH | isoniazid |
| RIF | rifampicin |
| PZA | pyrazinamide |
| EMB | ethambutol |
References
- Patzakis, M.J.; Zalavras, C.G. Chronic posttraumatic osteomyelitis and infected nonunion of the tibia: Current management concepts. J. Am. Acad. Orthop. Surg. 2005, 13, 417–427. [Google Scholar] [CrossRef] [PubMed]
- Donlan, R.M. Biofilm formation: A clinically relevant microbiological process. Clin. Infect. Dis. 2001, 33, 1387–1392. [Google Scholar] [CrossRef] [PubMed]
- Tulner, S.A.; Schaap, G.R.; Strackee, S.D.; Besselaar, P.P.; Luitse, J.S.; Marti, R.K. Long-term results of multiple-stage treatment for posttraumatic osteomyelitis of the tibia. J. Trauma 2004, 56, 633–642. [Google Scholar] [CrossRef] [PubMed]
- Birbrair, A.; Frenette, P.S. Niche heterogeneity in the bone marrow. Ann. N. Y. Acad. Sci. 2016, 1370, 82–96. [Google Scholar] [CrossRef]
- Bellapianta, J.; Gerdeman, A.; Sharan, A.; Lozman, J. Use of the reamer irrigator aspirator for the treatment of a 20-year recurrent osteomyelitis of a healed femur fracture. J. Orthop. Trauma 2007, 21, 343–346. [Google Scholar] [CrossRef]
- Zalavras, C.G.; Singh, A.; Patzakis, M.J. Novel technique for medullary canal débridement in tibia and femur osteomyelitis. Clin. Orthop. Relat. Res. 2007, 461, 31–34. [Google Scholar] [CrossRef]
- Zalavras, C.G.; Sirkin, M. Treatment of long bone intramedullary infection using the RIA for removal of infected tissue: Indications, method and clinical results. Injury 2010, 41, S43–S47. [Google Scholar] [CrossRef]
- Besal, R.; Adamič, P.; Beović, B.; Papst, L. Systemic Antimicrobial Treatment of Chronic Osteomyelitis in Adults: A Narrative Review. Antibiotics 2023, 12, 944. [Google Scholar] [CrossRef]
- Osmon, D.R.; Berbari, E.F.; Berendt, A.R.; Lew, D.; Zimmerli, W.; Steckelberg, J.M.; Rao, N.; Hanssen, A.; Wilson, W.R. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2013, 56, e1–e25. [Google Scholar] [CrossRef]
- Palestro, C.J. Radionuclide imaging of osteomyelitis. Semin. Nucl. Med. 2015, 45, 32–46. [Google Scholar] [CrossRef]
- Treglia, G.; Focacci, C.; Caldarella, C.; Mattoli, M.V.; Salsano, M.; Taralli, S.; Giordano, A. The role of nuclear medicine in the diagnosis of spondylodiscitis. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 20–25. [Google Scholar]
- Kim, C.; Lee, S.J.; Kim, J.Y.; Hwang, K.T.; Choi, Y.Y. Comparative Analysis of (99m)Tc-MDP Three-Phase Bone Scan with SPECT/CT and (99m)Tc-HMPAO-Labeled WBC SPECT/CT in the Differential Diagnosis of Clinically Suspicious Post-traumatic Osteomyelitis. Nucl. Med. Mol. Imaging 2017, 51, 40–48. [Google Scholar] [CrossRef] [PubMed]
- Shin, H.S.; Kim, M.B. Predictive Value of (99m)Tc DPD Bone SPECT/CT Uptake Ratio for Culture Results in Lower Limb Osteomyelitis. Diagnostics 2025, 15, 2109. [Google Scholar] [CrossRef] [PubMed]
- Pincher, B.; Fenton, C.; Jeyapalan, R.; Barlow, G.; Sharma, H.K. A systematic review of the single-stage treatment of chronic osteomyelitis. J. Orthop. Surg. Res. 2019, 14, 393. [Google Scholar] [CrossRef] [PubMed]
- Zhou, C.H.; Ren, Y.; Ali, A.; Meng, X.Q.; Zhang, H.A.; Fang, J.; Qin, C.H. Single-stage treatment of chronic localized tibial osteomyelitis with local debridement and antibiotic-loaded calcium sulfate implantation: A retrospective study of 42 patients. J. Orthop. Surg. Res. 2020, 15, 201. [Google Scholar] [CrossRef]
- Selvaratnam, V.; Roche, A.; Narayan, B.; Giotakis, N.; Mukhopadhaya, S.; Aniq, H.; Nayagam, S. Effectiveness of an Antibiotic-impregnated Bioabsorbable Carrier for the Treatment of Chronic Intramedullary and Diffuse Osteomyelitis. Strategies Trauma Limb. Reconstr. 2023, 18, 148–154. [Google Scholar]
- Wang, Y.; Li, J.; Zhang, X.; Yang, X.; Song, M.; Lv, K.; Xu, Y.; Shi, J. Clinical outcome of chronic haematogenous osteomyelitis of the femur or tibia in adults using selective segmental osteotomy and induced membrane technique. BMC Surg. 2025, 25, 137. [Google Scholar] [CrossRef]
- Arshad, Z.; Lau, E.J.; Aslam, A.; Thahir, A.; Krkovic, M. Management of chronic osteomyelitis of the femur and tibia: A scoping review. EFORT Open Rev. 2021, 6, 704–715. [Google Scholar] [CrossRef]
- Xue, B.; Pan, Y.; Wang, B.; Dang, H.; Li, T.; Yang, C.; Fan, J. Simultaneous reconstruction of tibial osteomyelitis-complicated soft tissue defects using free flap transplantation in conjunction with the masquelet technique: A retrospective study. BMC Musculoskelet. Disord. 2024, 25, 891. [Google Scholar] [CrossRef]
- Kliushin, N.M.; Burnashov, S.I.; Mekki, W.A.; Leonchuk, D.S.; Sudnitsyn, A.S. Treatment of postoperative tibial chronic osteomyelitis using bone transport techniques; an observational study. J. Clin. Orthop. Trauma 2022, 24, 101652. [Google Scholar] [CrossRef]
- Qin, C.; Xu, L.; Liao, J.; Fang, J.; Hu, Y. Management of Osteomyelitis-Induced Massive Tibial Bone Defect by Monolateral External Fixator Combined with Antibiotics-Impregnated Calcium Sulphate: A Retrospective Study. Biomed. Res. Int. 2018, 2018, 9070216. [Google Scholar] [CrossRef]
- Lorenzo, J.; Horowitz, M.; Choi, Y. Osteoimmunology: Interactions of the bone and immune system. Endocr. Rev. 2008, 29, 403–440. [Google Scholar] [CrossRef] [PubMed]
- Takayanagi, H. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 2007, 7, 292–304. [Google Scholar] [CrossRef] [PubMed]
- Tsukasaki, M.; Takayanagi, H. Osteoimmunology: Evolving concepts in bone-immune interactions in health and disease. Nat. Rev. Immunol. 2019, 19, 626–642. [Google Scholar] [CrossRef] [PubMed]
- Walsh, M.C.; Kim, N.; Kadono, Y.; Rho, J.; Lee, S.Y.; Lorenzo, J.; Choi, Y. Osteoimmunology: Interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 2006, 24, 33–63. [Google Scholar] [CrossRef]
- Chen, S.; Saeed, A.; Liu, Q.; Jiang, Q.; Xu, H.; Xiao, G.G.; Rao, L.; Duo, Y. Macrophages in immunoregulation and therapeutics. Signal Transduct. Target. Ther. 2023, 8, 207. [Google Scholar] [CrossRef]
- Boyce, B.F.; Xing, L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 2008, 473, 139–146. [Google Scholar] [CrossRef]
- Dong, Q.; Zhou, J.; Feng, M.; Kong, L.; Fang, B.; Zhang, Z. A review of bacterial and osteoclast differentiation in bone infection. Microb. Pathog. 2024, 197, 107102. [Google Scholar] [CrossRef]
- Ren, L.R.; Wang, Z.H.; Wang, H.; He, X.Q.; Song, M.G.; Xu, Y.Q. Staphylococcus Aureus Induces Osteoclastogenesis via the NF-κB Signaling Pathway. Med. Sci. Monit 2017, 23, 4579–4590. [Google Scholar] [CrossRef]
- Krauss, J.L.; Roper, P.M.; Ballard, A.; Shih, C.C.; Fitzpatrick, J.A.J.; Cassat, J.E.; Ng, P.Y.; Pavlos, N.J.; Veis, D.J. Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly. mBio 2019, 10, e02447-19. [Google Scholar] [CrossRef]





| Patient No. | Sex | Age | Sx Duration (mo) | Location | Size 1 (cm3) | Combined Septic Knee | Cierny–Mader Class | Gustilo–Anderson Class | Pathogen | I/F Using Implants | Bone Cement Filling | F/U Period (mo) | Treatment Outcome | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contiguous | Post-traumatic | 1 | M | 69 | 16.1 | Meta to Dia | 13.4 | - | IIIA | II | CoNS | - | yes | 12.0 | resolved |
| 2 | M | 66 | 7.6 | Meta to Dia | 14.3 | - | IVA | IIIB | GBS | yes | - | 50.5 | resolved | ||
| 3 | M | 56 | 49.6 | Meta | 121.8 | yes | IVB L | IIIB | C. albicans | yes | - | 87.4 | IIIA 2 | ||
| 4 | M | 57 | 276.0 | Meta to Dia | 82.9 | - | IVA | NA | CoNS | yes | - | 75.4 | resolved | ||
| 5 | M | 71 | 600.0 | Dia | 18.5 | - | IIIA | NA | S. marcescens | - | - | 46.5 | resolved | ||
| 6 | F | 57 | 1.9 | Meta to Dia | 17.8 | - | IVB L | IIIB | MRSA | yes | - | 104.8 | IIA 2 | ||
| SSI | 7 | M | 63 | 35.9 | Meta | 10.6 | - | IIIA | - | negative 3 | - | - | 39.2 | resolved | |
| 8 | M | 43 | 12.3 | Meta to Dia | 104.7 | yes | IVB S4 | - | MRSA | yes | yes | 61.3 | IIA 2 | ||
| Idiopathic | 9 | M | 54 | 3.0 | Meta | 13.1 | - | IIIA | - | MSSA | - | - | 2.6 | resolved | |
| 10 | F | 23 | 12.0 | Meta | 10.2 | - | IIIA | - | negative 3 | - | - | 28.7 | resolved | ||
| 11 | F | 76 | 4.0 | Meta to Dia | 23.5 | - | IIIA | - | MSSA | - | - | 63.3 | resolved | ||
| 12 | M | 71 | 12.0 | Meta to Dia | 38.2 | - | IIIA | - | negative 3 | - | - | 60.5 | resolved | ||
| MTB | 13 | F | 33 | 60.0 | Meta to Dia | 11.9 | - | IIIB S5 | - | MTB | - | yes | 104.9 | resolved | |
| 14 | M | 69 | 5.0 | Meta | 14.0 | yes 7 | IIIC 6 | - | MTB | - | yes | 14.4 | resolved 8 | ||
| Mean ± SD (min-max) | - | - | 57.7 ± 15.4 (23–76) | 78.2 ± 166.1 (1.90–600.0) | - | 13.4 ± 38.2 (10.2–121.8) | - | - | - | - | - | - | 53.7 ± 32.6 (2.6–104.9) | - | |
| Patient No. | Laboratory Results at Diagnosis | Medical Treatment (Antibiotics) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IV | PO | Anti-Loaded Cement | |||||||||
| WBC (103/μL) | ESR (mm/hr) | CRP (mg/L) | Anti | Dose (mg/Day) | Day 1 | Anti | Dose (mg/Day) | Day 2 | Anti | Conc. (mg Anti/ g Cement) | |
| 1 | 7.77 | 35.0 | 0.9 | Uba | 1200 | 21 | AUG | 1875 | 7 | VCM | 45 |
| 2 | 5.46 | 88.0 | 37.9 | VCM | 2000 | 12 | AUG | 1875 | 14 | - | - |
| Citopcin | 1000 | ||||||||||
| 3 | 7.54 | 62.0 | 11.5 | Uba | 2000 | 4 | AUG | 1875 | 14 | - | - |
| Tobra | 75 | Citopcin | 1000 | ||||||||
| 4 | 6.81 | 6.0 | 0.5 | VCM | 2000 | 14 | AUG | 1875 | 14 | - | - |
| Citopcin | 1000 | ||||||||||
| 5 | 7.88 | 3.2 | 11.2 | Flu | 1000 | 2 | AUG | 1875 | 40 | - | - |
| Citopcin | 1000 | ||||||||||
| Fullgram | 450 | ||||||||||
| 6 | 3.91 | 26.0 | 51.4 | VCM | 2000 | 14 | AUG | 1875 | 21 | - | - |
| Citopcin | 1000 | ||||||||||
| 7 | 5.5 | 7.0 | 8.2 | Uba | 1200 | 12 | AUG | 1875 | 14 | - | - |
| AMK | 1000 | Citopcin | 1000 | ||||||||
| 8 | 25.53 | 95.0 | 64.8 | Uba | 1200 | 28 | Duricef | 1000 | 30 | VCM | 45 |
| 9 | 8.45 | 49.0 | 2.0 | Uba | 1200 | 8 | AUG | 1875 | 14 | - | - |
| AMK | 1000 | Citopcin | 1000 | ||||||||
| 10 | 9.69 | 29.0 | 36.0 | VCM | 2000 | 18 | AUG | 1875 | 14 | - | - |
| Citopcin | 1000 | ||||||||||
| 11 | 8.46 | 72.0 | 5.3 | VCM | 2000 | 7 | - | - | - | - | - |
| 12 | 11.2 | 71.0 | 51.6 | VCM | 2000 | 7 | Omnicef | 300 | 21 | ||
| 13 | 8.38 | 28.0 | 0.8 | - | - | - | Myambutol | 800 | 180 | - | - |
| INAH | 300 | ||||||||||
| RIF | 600 | ||||||||||
| PZA | 1500 | ||||||||||
| 14 | 7.7 | 74.0 | 108.7 | - | - | - | EMB | 275 | 180 | - | - |
| INAH | 75 | ||||||||||
| RIF | 600 | ||||||||||
| PZA | 400 | ||||||||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Park, Y.-C.; Kim, S.H. New Alternative Surgical Technique for Managing Proximal Tibia Chronic Osteomyelitis: Anterior Approach with Establishment of Bone Marrow Communication via Intramedullary Reaming. J. Clin. Med. 2026, 15, 129. https://doi.org/10.3390/jcm15010129
Park Y-C, Kim SH. New Alternative Surgical Technique for Managing Proximal Tibia Chronic Osteomyelitis: Anterior Approach with Establishment of Bone Marrow Communication via Intramedullary Reaming. Journal of Clinical Medicine. 2026; 15(1):129. https://doi.org/10.3390/jcm15010129
Chicago/Turabian StylePark, Young-Chang, and Seung Hyun Kim. 2026. "New Alternative Surgical Technique for Managing Proximal Tibia Chronic Osteomyelitis: Anterior Approach with Establishment of Bone Marrow Communication via Intramedullary Reaming" Journal of Clinical Medicine 15, no. 1: 129. https://doi.org/10.3390/jcm15010129
APA StylePark, Y.-C., & Kim, S. H. (2026). New Alternative Surgical Technique for Managing Proximal Tibia Chronic Osteomyelitis: Anterior Approach with Establishment of Bone Marrow Communication via Intramedullary Reaming. Journal of Clinical Medicine, 15(1), 129. https://doi.org/10.3390/jcm15010129

